{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T08:28:17Z","timestamp":1769502497177,"version":"3.49.0"},"reference-count":41,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T00:00:00Z","timestamp":1632873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: The main reason for Newborn screening (NBS) for congenital adrenal hyperplasia (CAH) is to prevent adrenal insufficiency that can lead to life-threatening conditions. On the other hand, screening programs are not always sensitive and effective enough to detect the disease. We aimed to evaluate impact of the national NBS on the clinical presentation of patients with CAH in Lithuania. Materials and Methods: A retrospective study was performed on data of 88 patients with CAH from 1989 to 2020. Patients with confirmed CAH were divided into two groups: (1) 75 patients diagnosed before NBS: 52 cases with salt-wasting (SW), 21 with simple virilising (SV) and two with non-classical (NC) form; (2) 13 patients diagnosed with NBS: 12 cases with SW and 1 case with SV form. For the evaluation of NBS effectiveness, data of only male infants with salt-wasting CAH were analysed (n = 36, 25 unscreened and nine screened). Data on gestational age, birth weight, weight, symptoms, and laboratory tests (serum potassium and sodium levels) on the day of diagnosis, were analysed. Results: A total of 158,486 neonates were screened for CAH from 2015 to 2020 in Lithuania and CAH was confirmed in 13 patients (12 SW, one\u2013SV form), no false negative cases were found. The sensitivity and specificity of NBS program for classical CAH forms were 100%; however, positive predictive value was only 4%. There were no significant differences between unscreened and screened male infant groups in terms of age at diagnosis, serum potassium, and serum sodium levels. Significant differences were found in weight at diagnosis between the groups (\u22121.67 \u00b1 1.12 SDS versus 0.046 \u00b1 1.01 SDS of unscreened and screened patients respectively, p = 0.001). Conclusions: The sensitivity and specificity of NBS for CAH program were 100%, but positive predictive value\u2014only 4%. Weight loss was significantly lower and the weight SDS at diagnosis was significantly higher in the group of screened patients.<\/jats:p>","DOI":"10.3390\/medicina57101035","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T00:03:42Z","timestamp":1632960222000},"page":"1035","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Impact of Newborn Screening on Clinical Presentation of Congenital Adrenal Hyperplasia"],"prefix":"10.3390","volume":"57","author":[{"given":"R\u016bta","family":"Navardauskait\u0117","sequence":"first","affiliation":[{"name":"Institute of Endocrinology, Medical Academy, Lithuanian University of Health Sciences, LT-50009 Kaunas, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kornelija","family":"Banevi\u010di\u016bt\u0117","sequence":"additional","affiliation":[{"name":"Institute of Endocrinology, Medical Academy, Lithuanian University of Health Sciences, LT-50009 Kaunas, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jurgita","family":"Songailien\u0117","sequence":"additional","affiliation":[{"name":"Medical Faculty, Institute of Biomedical Sciences, Vilnius University, LT-03101 Vilnius, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Grigalionien\u0117","sequence":"additional","affiliation":[{"name":"Medical Faculty, Institute of Biomedical Sciences, Vilnius University, LT-03101 Vilnius, Lithuania"},{"name":"Centre for Medical Genetics, Vilnius University Hospital Santaros Klinikos, LT-08661 Vilnius, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darius","family":"\u010cere\u0161kevi\u010dius","sequence":"additional","affiliation":[{"name":"Department of Genetics and Molecular Medicine, Medical Academy, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marius","family":"\u0160ukys","sequence":"additional","affiliation":[{"name":"Department of Genetics and Molecular Medicine, Medical Academy, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giedr\u0117","family":"Mockevicien\u0117","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Medical Academy, Lithuanian University of Health Sciences, LT-50161 Kaunas, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marija","family":"Smirnova","sequence":"additional","affiliation":[{"name":"Centre for Medical Genetics, Vilnius University Hospital Santaros Klinikos, LT-08661 Vilnius, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Algirdas","family":"Utkus","sequence":"additional","affiliation":[{"name":"Medical Faculty, Institute of Biomedical Sciences, Vilnius University, LT-03101 Vilnius, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0108-9305","authenticated-orcid":false,"given":"Rasa","family":"Verkauskien\u0117","sequence":"additional","affiliation":[{"name":"Institute of Endocrinology, Medical Academy, Lithuanian University of Health Sciences, LT-50009 Kaunas, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,29]]},"reference":[{"key":"ref_1","first-page":"16","article-title":"Congenital adrenal hyperplasia\u2014Current insights in pathophysiology, diagnostics and management","volume":"7","author":"Speiser","year":"2021","journal-title":"Endocr. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1515\/jpem-2018-0342","article-title":"A pilot study on newborn screening for congenital adrenal hyperplasia in Beijing","volume":"32","author":"Gong","year":"2019","journal-title":"J. Pediatric Endocrinol. Metab."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jpag.2017.04.001","article-title":"Congenital Adrenal Hyperplasia","volume":"30","author":"Witchel","year":"2017","journal-title":"J. Pediatric Adolesc. Gynecol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/S0140-6736(17)31431-9","article-title":"Congenital adrenal hyperplasia","volume":"390","author":"Arlt","year":"2017","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1053\/j.semperi.2015.03.002","article-title":"Current status of newborn screening worldwide: 2015","volume":"39","author":"Therrell","year":"2015","journal-title":"Semin. Perinatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"E161","DOI":"10.1210\/jc.2010-0319","article-title":"Comprehensive genetic analysis of 182 unrelated families with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"96","author":"Finkielstain","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/nar\/29.1.308","article-title":"dbSNP: The NCBI database of genetic variation","volume":"29","author":"Sherry","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1210\/jc.2018-01865","article-title":"Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline","volume":"103","author":"Speiser","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/humu.10212","article-title":"Human Gene Mutation Database (HGMD): 2003 update","volume":"21","author":"Stenson","year":"2003","journal-title":"Hum. Mutat."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/humu.22981","article-title":"HGVS Recommendations for the Description of Sequence Variants: 2016 Update","volume":"37","author":"Dalgleish","year":"2016","journal-title":"Hum. Mutat."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1136\/archdischild-2018-315972","article-title":"Evaluation of the Dutch neonatal screening for congenital adrenal hyperplasia","volume":"104","author":"Boelen","year":"2019","journal-title":"Arch. Dis. Child."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1210\/jc.2014-3168","article-title":"Newborn screening for congenital adrenal hyperplasia in New Zealand, 1994\u20132013","volume":"100","author":"Heather","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Tsuji, A., Konishi, K., Hasegawa, S., Anazawa, A., Onishi, T., Ono, M., Morio, T., Kitagawa, T., and Kashimada, K. (2015). Newborn screening for congenital adrenal hyperplasia in Tokyo, Japan from 1989 to 2013: A retrospective population-based study. BMC Pediatrics, 15.","DOI":"10.1186\/s12887-015-0529-y"},{"key":"ref_15","first-page":"1","article-title":"Newborn screening for congenital adrenal hyperplasia in New York State","volume":"7","author":"Pearce","year":"2016","journal-title":"Mol. Genet. Metab. Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jpeds.2019.12.057","article-title":"Clinical Impact and Cost Efficacy of Newborn Screening for Congenital Adrenal Hyperplasia","volume":"220","author":"Fox","year":"2020","journal-title":"J. Pediatrics"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Tsuji-Hosokawa, A., and Kashimada, K. (2021). Thirty-Year Lessons from the Newborn Screening for Congenital Adrenal Hyperplasia (CAH) in Japan. Int. J. Neonatal Screen., 7.","DOI":"10.3390\/ijns7030036"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Sontag, M.K., Miller, J.I., McKasson, S., Sheller, R., Edelman, S., Yusuf, C., Singh, S., Sarkar, D., Bocchini, J., and Scott, J. (2020). Newborn screening timeliness quality improvement initiative: Impact of national recommendations and data repository. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0231050"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1001\/jamapediatrics.2013.5321","article-title":"Nationwide neonatal screening for congenital adrenal hyperplasia in sweden: A 26-year longitudinal prospective population-based study","volume":"168","author":"Wedell","year":"2014","journal-title":"JAMA Pediatrics"},{"key":"ref_20","first-page":"170","article-title":"A comparative cost analysis of newborn screening for classic congenital adrenal hyperplasia in Texas","volume":"113","author":"Brosnan","year":"1998","journal-title":"Public Health Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"659492","DOI":"10.3389\/fped.2021.659492","article-title":"The Cost-Effectiveness of Congenital Adrenal Hyperplasia Newborn Screening in Brazil: A Comparison between Screened and Unscreened Cohorts","volume":"9","author":"Haddad","year":"2021","journal-title":"Front. Pediatrics"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/adc.70.3.214","article-title":"Presentation, acute illness, and learning difficulties in salt wasting 21-hydroxylase deficiency","volume":"70","author":"Donaldson","year":"1994","journal-title":"Arch. Dis. Child."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Baily, M.A., and Murray, T.H. (2009). Cost effectiveness as a criterion for newborn screening policy decisions. Ethics and Newborn Genetic Screening: New Technologies, New Challenges, Johns Hopkins University Press.","DOI":"10.56021\/9780801891519"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Lousada, L.M., Mendonca, B.B., and Bachega, T.A.S.S. (2021). Adrenal crisis and mortality rate in adrenal insufficiency and congenital adrenal hyperplasia. Arch. Endocrinol. Metab., Epub ahead of print.","DOI":"10.20945\/2359-3997000000392"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1159\/000481660","article-title":"Adrenal Crises in Children: Perspectives and Research Directions","volume":"89","author":"Rushworth","year":"2018","journal-title":"Horm. Res. Paediatr."},{"key":"ref_26","first-page":"e99","article-title":"Physiological weight loss in the breastfed neonate: A systematic review","volume":"2","author":"Courant","year":"2008","journal-title":"Open Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e20162625","DOI":"10.1542\/peds.2016-2625","article-title":"Weight Change Nomograms for the First Month After Birth","volume":"138","author":"Paul","year":"2016","journal-title":"Pediatrics"},{"key":"ref_28","first-page":"362","article-title":"Congenital adrenal hyperplasia: Neonatal mass screening compared with clinical diagnosis only in the Emilia-Romagna region of Italy, 1980\u20131995","volume":"98","author":"Balsamo","year":"1996","journal-title":"Pediatrics"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000486393","article-title":"Incidence and Characteristics of Adrenal Crisis in Children Younger than 7 Years with 21-Hydroxylase Deficiency: A Nationwide Survey in Japan","volume":"89","author":"Ishii","year":"2018","journal-title":"Horm. Res. Paediatr."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1210\/jc.2018-02468","article-title":"Combined Gestational Age- and Birth Weight-Adjusted Cutoffs for Newborn Screening of Congenital Adrenal Hyperplasia","volume":"104","author":"Blau","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Speiser, P.W., Chawla, R., Chen, M., Diaz-Thomas, A., Finlayson, C., Rutter, M.M., Sandberg, D.E., Shimy, K., Talib, R., and Cerise, J. (2020). Newborn Screening Protocols and Positive Predictive Value for Congenital Adrenal Hyperplasia Vary across the United States. Int. J. Neonatal Screen., 6.","DOI":"10.3390\/ijns6020037"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"E68","DOI":"10.1542\/peds.108.4.e68","article-title":"Neonatal screening for congenital adrenal hyperplasia: 17-hydroxyprogesterone levels and CYP21 genotypes in preterm infants","volume":"108","author":"Wedell","year":"2001","journal-title":"Pediatrics"},{"key":"ref_33","first-page":"266","article-title":"Adrenal steroidogenesis in very low birth weight preterm infants","volume":"78","author":"Hingre","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jped.2018.03.003","article-title":"Clinical and molecular profile of newborns with confirmed or suspicious congenital adrenal hyperplasia detected after a public screening program implementation","volume":"95","author":"Kopacek","year":"2019","journal-title":"J. Pediatrics"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4103\/2230-8210.145077","article-title":"Phenotypic variability of hyperandrogenemia in females heterozygous for CYP21A2 mutations","volume":"18","author":"Neocleous","year":"2014","journal-title":"Indian J. Endocrinol. Metab."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1210\/jc.2004-1728","article-title":"Carrier frequency of congenital adrenal hyperplasia (21-hydroxylase deficiency) in a middle European population","volume":"90","author":"Nowotny","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_37","first-page":"2845","article-title":"The spectrum of molecular defects of the CYP21 gene in the Hellenic population: Variable concordance between genotype and phenotype in the different forms of congenital adrenal hyperplasia","volume":"86","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000156115","article-title":"The cost effectiveness of screening newborns for congenital adrenal hyperplasia","volume":"12","author":"Yoo","year":"2009","journal-title":"Public Health Genom."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Lajic, S., Karlsson, L., Zetterstr\u00f6m, R.H., Falhammar, H., and Nordenstr\u00f6m, A. (2020). The Success of a Screening Program Is Largely Dependent on Close Collaboration between the Laboratory and the Clinical Follow-Up of the Patients. Int. J. Neonatal Screen., 26.","DOI":"10.3390\/ijns6030068"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Grosse, S.D., and Van Vliet, G. (2020). Challenges in Assessing the Cost-Effectiveness of Newborn Screening: The Example of Congenital Adrenal Hyperplasia. Int. J. Neonatal Screen, 6.","DOI":"10.3390\/ijns6040082"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"bvz013","DOI":"10.1210\/jendso\/bvz013","article-title":"Adverse Outcomes and Economic Burden of Congenital Adrenal Hyperplasia Late Diagnosis in the Newborn Screening Absence","volume":"4","author":"Miranda","year":"2019","journal-title":"J. Endocr. Soc."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/10\/1035\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:07:00Z","timestamp":1760166420000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/10\/1035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,29]]},"references-count":41,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["medicina57101035"],"URL":"https:\/\/doi.org\/10.3390\/medicina57101035","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,29]]}}}